Shanghai ChemPartner Announces Being Selected as Antibody Service Partner by Shenogen Pharma Group
SHANGHAI, March 16, 2011 /PRNewswire-Asia/ — ShangPharma Corporation (NYSE: SHP) (“ShangPharma” or the “Company”), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop …
Isis Pharma announces ISIS-CRPRx Phase 1 trial results in diseases with elevated CRP
Isis Pharmaceuticals, Inc. announced today the results from a Phase 1 clinical trial in which ISIS-CRPRx produced statistically significant reductions in C-reactive protein in the cohort of subjects in the study with elevated CRP.
NSF International acquires biotech & pharma lab company
Incorporated into the parent company’s Health Sciences Division, NSF Pharmalytica will operate mainly as a contract laboratory focusing on Good Laboratory Practice (GLP) and Good Manufacturing Practises (GMP).
Celtic Pharma Announces Presentation of Preclinical Data at the 69th Annual Meeting of the AAD in New Orleans
LONDON, NEW YORK and HAMILTON, Bermuda, Feb. 7, 2011 /PRNewswire/ — Celtic Pharmaceutical Holdings L.P. (“Celtic Pharma”), the global private equity firm focused on the biotechnology and pharmaceutical industries, announced today the presentation of key in-vitro data at the American Academy of Dermatology (AAD) 69th annual meeting in New Orleans (4-8 February, 2011) for TDT 067, terbinafine in …
Celtic Pharma Announces Presentation of Preclinical Data at the 69th Annual Meeting of the AAD in New Orleans
LONDON, NEW YORK and HAMILTON, Bermuda, Feb. 7, 2011 /PRNewswire/ — Celtic Pharmaceutical Holdings L.P. (“Celtic Pharma”), the global private equity firm focused on the biotechnology and pharmaceutical industries, announced today the presentation of key in-vitro data at the American Academy of Dermatology (AAD) 69th annual meeting in New Orleans (4-8 February, 2011) for TDT 067, terbinafine in …
plus sur wizdeo.com . Entretien avec Serge Runser le chef d’établissement de Novartis Pharma. (DROITS RESERVES . Pour toute exploitation sur TV, web, mobile, aller sur wizdeo.com )
Dr. Maxine Gowen, Wharton ’02 and CEO of Trevena, Inc., to Speak on “Big Pharma vs. Biotech: Innovation in an Era of …
PHILADELPHIA, PA–(Marketwire – 11/05/10) – Dr. Maxine Gowen, Chief Executive Officer of Trevena, Inc., will be presenting on the topic of innovation in the pharmaceutical industry and the changing relationship between big pharma and biotech. Dr. Gowen remarked: “We are witnessing the adoption of the biotech culture by the world’s leading pharmaceutical companies, in an effort to accelerate …
Pharma and Biotech Firms Are Rethinking Their Approach to Outsourcing, According to Tufts Center for the Study of Drug …
BOSTON, MA–(Marketwire – 10/26/10) – The current business climate is challenging pharmaceutical and biotech companies to rethink their approach to outsourcing and how best to build alliances with external service providers as part of a long term drug development strategy, according to a panel of pharmaceutical and biotech industry leaders recently convened by the Tufts Center for the Study of …
